Articles
Media
Publications
Conferences
CME/CE
Resources
Subscribe

Spotlight -

ZEISS Clinical Cases|

Heidelberg Engineering: Enhancing the Patient Journey

Nitish Mehta, MD

Articles by Nitish Mehta, MD

At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.

ARVO 2025: Nitish Mehta, MD, provides real-world insights from aflibercept 8 mg for treatment-naive diabetic macular oedema

ByMartin David Harp,Hattie Hayes,Nitish Mehta, MD

May 6th 2025

Latest Updated Articles

Trending on Ophthalmology Times Europe

FLORetina 2025: New horizons in research and risk management for ROP

FLORetina 2025: Antithrombotic use examined in wet AMD submacular hemorrhage

FLORetina 2025: Remotely managing patients with neovascular age-related macular degeneration

FLORetina 2025: Artificial intelligence at the frontlines of ROP care

FLORetina 2025: Multimodal deep learning for CKD diagnosis using retinal images and urine dipstick data

© 2025 MJH Life Sciences^®

All rights reserved.